Company
Curve Biosciences
Curve uses Whole-Body Intelligence to monitor chronic diseases.
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Legal name
- Curve Biosciences
Claim, correct or request removal
Record updated 28 September 2026
About
We create Whole-Body Intelligence models from our Whole-Body Atlas, the first molecular blueprint of the body. These models fuel our Whole-Body Blood Tests™, which monitor the organ health of chronic disease patients to deliver optimal accuracy and outcomes.
Funding snapshot
- Total raised
- $17.7MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $17.7M2024-05-01
Funding rounds
- Round, 2024
- $17.7M2024-05-01, SEC form D sold, 64 investors
Products
- Other
- Whole-Body Blood Tests™
Loading relationship preview